Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

OPC 108459

Next Previous
Drug Profile

OPC 108459

Alternative Names: OPC-108459

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Otsuka Pharmaceutical Development & Commercialization
  • Class Antiarrhythmics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Atrial fibrillation

Most Recent Events

  • 26 Feb 2018 Otsuka Pharmaceutical, prior to February 2018, in-licenses Ligand Pharmaceuticals' Captisol® technology for the development of OPC-108459
  • 13 Sep 2016 Discontinued - Phase-I for Atrial fibrillation in USA, Japan, United Kingdom, Spain, Netherlands, Denmark, Germany, Italy (IV) before September 2016 because of insufficient data in phase I trial (Otsuka Pharmaceuticals pipeline, September 2016)
  • 23 Sep 2014 Phase-I clinical trials in Atrial fibrillation in United Kingdom, Italy, Germany, Netherlands and Spain (IV)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top